v2.4.0.8
Condensed Consolidating Financial Information (Cash Flows) (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended 9 Months Ended
Mar. 31, 2012
Jun. 30, 2013
Jun. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Dec. 31, 2011
Cash flows from operating activities            
Net cash provided by operating activities $ 147,481 $ 233,783   $ 233,783 $ 147,481  
Cash flows from investing activities            
Capital expenditures (101,322) (100,618)   (100,618) (101,322)  
Escrow Deposit Disbursements Related to Property Acquisition       0 350,000  
Proceeds from sale of Echelon, net   343,750   343,750 0  
Cash paid for exercise of LVE option   (187,000)   (187,000) 0  
Investment in subsidiaries 0 0        
Other investing activities 4,054 198        
Net cash provided by (used in) investing activities (447,268) 61,205   61,205 (447,268)  
Cash flows from financing activities            
Borrowings under bank credit facility 1,157,900 3,276,975        
Payments under bank credit facility (1,378,175) (3,335,813)        
Payments on long-term debt (2,881)          
Proceeds from issuance of non-recourse debt by variable interest entity 341,168     0 2,668  
proceeds from issuance of acquisition financing       0 (350,000)  
Debt financing costs, net   (36,396)   (36,396) (2,881)  
Payments on notes payable   (10,818)   (10,818) 0  
Payments on early retirements of debt   (500,272)   (500,272) 0  
Proceeds from stock options exercised   13,591   13,591 0  
Other financing activities (427) (354)        
Net cash used in financing activities 466,830 (376,620)   (376,620) 466,830  
Cash Flows from Discontinued Operations            
Cash flows from operating activities   (2,144) (1,636) (2,144) (1,636)  
Cash flows from investing activities   56,751 (392) 56,751 (392)  
Cash flows from financing activities   0 0 0 0  
Net Cash Provided by (Used in) Discontinued Operations   54,607 (2,028) 54,607 (2,028)  
Cash and cash equivalents, beginning of period 178,091 192,545 178,091 192,545 178,091  
Change in cash classified as discontinued operations   283   283 373 373
Cash and cash equivalents, end of period 343,479 165,803   165,803 343,479  
Cash and Cash Equivalents, Period Increase (Decrease) 165,015 (27,025)   (27,025) 165,015  
Parent
           
Cash flows from operating activities            
Net cash provided by operating activities (101,627) 143,937        
Cash flows from investing activities            
Capital expenditures (40,641) (22,922)        
Proceeds from sale of Echelon, net   343,750        
Cash paid for exercise of LVE option   (187,000)        
Investment in subsidiaries 88 (4,233)        
Other investing activities 0 0        
Net cash provided by (used in) investing activities (40,553) 134,470        
Cash flows from financing activities            
Borrowings under bank credit facility 642,600 2,711,375        
Payments under bank credit facility (836,375) (2,738,325)        
Payments on long-term debt (2,664)          
Proceeds from issuance of non-recourse debt by variable interest entity 338,500          
Debt financing costs, net   (23,562)        
Payments on notes payable   (10,341)        
Payments on early retirements of debt   459,278        
Proceeds from Contributions from Affiliates   9,500        
Proceeds from stock options exercised   13,591        
Other financing activities 117 (354)        
Net cash used in financing activities 142,178 (280,927)        
Cash Flows from Discontinued Operations            
Cash flows from operating activities   0 0      
Cash flows from investing activities   0 0      
Cash flows from financing activities   0 0      
Net Cash Provided by (Used in) Discontinued Operations   0 0      
Cash and cash equivalents, beginning of period 364 2,520 364 2,520 364  
Change in cash classified as discontinued operations   0       0
Cash and cash equivalents, end of period 362 0   0    
Cash and Cash Equivalents, Period Increase (Decrease) (2) (2,520)        
Guarantor Subsidiaries
           
Cash flows from operating activities            
Net cash provided by operating activities 17,141 16,964        
Cash flows from investing activities            
Capital expenditures (26,807) (36,191)        
Proceeds from sale of Echelon, net   0        
Cash paid for exercise of LVE option             
Investment in subsidiaries 0 0        
Other investing activities 225 0        
Net cash provided by (used in) investing activities (26,582) (36,191)        
Cash flows from financing activities            
Borrowings under bank credit facility 0 0        
Payments under bank credit facility 0 0        
Payments on long-term debt 0          
Proceeds from issuance of non-recourse debt by variable interest entity 0          
Debt financing costs, net   0        
Payments on notes payable   0        
Other financing activities (544) 0        
Net cash used in financing activities (544) 0        
Cash Flows from Discontinued Operations            
Cash flows from operating activities   0 0      
Cash flows from investing activities   0 0      
Cash flows from financing activities   0 0      
Net Cash Provided by (Used in) Discontinued Operations   0 0      
Cash and cash equivalents, beginning of period 128,185 118,714 128,185 118,714 128,185  
Change in cash classified as discontinued operations   0       0
Cash and cash equivalents, end of period 118,200 99,487   99,487    
Cash and Cash Equivalents, Period Increase (Decrease) (9,985) (19,227)        
Non-Guarantor Subsidiaries (100% Owned)
           
Cash flows from operating activities            
Net cash provided by operating activities 190,413 12,695        
Cash flows from investing activities            
Capital expenditures 120 (25,107)        
Escrow Deposit Disbursements Related to Property Acquisition         (350,000)  
Proceeds from sale of Echelon, net   0        
Cash paid for exercise of LVE option             
Investment in subsidiaries 0 0        
Other investing activities 20 222        
Net cash provided by (used in) investing activities (349,860) (24,885)        
Cash flows from financing activities            
Borrowings under bank credit facility 0 268,500        
Payments under bank credit facility 0 (296,688)        
Payments on long-term debt 0          
Proceeds from issuance of non-recourse debt by variable interest entity 0          
proceeds from issuance of acquisition financing         350,000  
Debt financing costs, net   (10,288)        
Payments on notes payable   (477)        
Proceeds from Contributions from Affiliates   (9,500)        
Other financing activities 0 0        
Net cash used in financing activities 350,000 (48,453)        
Cash Flows from Discontinued Operations            
Cash flows from operating activities   (2,144) (1,636)      
Cash flows from investing activities   56,751 (392)      
Cash flows from financing activities   0 0      
Net Cash Provided by (Used in) Discontinued Operations   54,607 (2,028)      
Cash and cash equivalents, beginning of period 3,279 36,619 3,279 36,619 3,279  
Change in cash classified as discontinued operations   283       373
Cash and cash equivalents, end of period 192,177 30,866   30,866    
Cash and Cash Equivalents, Period Increase (Decrease) 188,525 (6,036)        
Non-Guarantor Subsidiaries (Not 100% Owned)
           
Cash flows from operating activities            
Net cash provided by operating activities 41,554 64,420        
Cash flows from investing activities            
Capital expenditures (33,994) (16,398)        
Proceeds from sale of Echelon, net   0        
Cash paid for exercise of LVE option             
Investment in subsidiaries (88) 0        
Other investing activities 3,809 (24)        
Net cash provided by (used in) investing activities (30,273) (16,422)        
Cash flows from financing activities            
Borrowings under bank credit facility 515,300 297,100        
Payments under bank credit facility (541,800) (300,800)        
Payments on long-term debt (217)          
Proceeds from issuance of non-recourse debt by variable interest entity 2,668          
Debt financing costs, net   (2,546)        
Payments on notes payable   0        
Other financing activities 0 0        
Net cash used in financing activities (24,804) (47,240)        
Cash Flows from Discontinued Operations            
Cash flows from operating activities   0 0      
Cash flows from investing activities   0 0      
Cash flows from financing activities   0 0      
Net Cash Provided by (Used in) Discontinued Operations   0 0      
Cash and cash equivalents, beginning of period 46,263 34,692 46,263 34,692 46,263  
Change in cash classified as discontinued operations   0       0
Cash and cash equivalents, end of period 32,740 35,450   35,450    
Cash and Cash Equivalents, Period Increase (Decrease) (13,523) 758        
Eliminations
           
Cash flows from operating activities            
Net cash provided by operating activities 0 (4,233)        
Cash flows from investing activities            
Capital expenditures 0 0        
Proceeds from sale of Echelon, net   0        
Cash paid for exercise of LVE option             
Investment in subsidiaries 0 4,233        
Other investing activities 0           
Net cash provided by (used in) investing activities 0 4,233        
Cash flows from financing activities            
Borrowings under bank credit facility 0           
Payments under bank credit facility 0           
Payments on long-term debt 0          
Proceeds from issuance of non-recourse debt by variable interest entity 0          
Debt financing costs, net             
Payments on notes payable             
Other financing activities 0           
Net cash used in financing activities 0 0        
Cash Flows from Discontinued Operations            
Cash flows from operating activities   0 0      
Cash flows from investing activities   0 0      
Cash flows from financing activities   0 0      
Net Cash Provided by (Used in) Discontinued Operations   0 0      
Cash and cash equivalents, beginning of period 0 0 0 0 0  
Change in cash classified as discontinued operations   0       0
Cash and cash equivalents, end of period 0 0   0    
Cash and Cash Equivalents, Period Increase (Decrease) $ 0 $ 0